University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Coley, H"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 62.

Article

Syed, N, Langer, J, Janczar, K, Singh, P, Roncaroli, F, Lo Nigro, C, Lattanzio, L, Coley, HM, Hatzimichael, E, Bomalaski, J, Szlosarek, P, Awad, M, O'Neil, K and Crook, T (2013) Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma Cell Death and Disease, 4 (1).

Neves, V, Heister, E, Costa, S, Tîlmaciu, C, Flahaut, E, Soula, B, Coley, HM, McFadden, J and Silva, SR (2012) Design of double-walled carbon nanotubes for biomedical applications. Nanotechnology, 23 (36).

Heister, E, Neves, V, Lamprecht, C, Silva, SRP, Coley, HM and McFadden, J (2012) Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes Carbon, 50 (2). pp. 622-632.

Heister, E, Neves, V, Lamprecht, C, Silva, SRP, Coley, HM and McFadden, J (2012) Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes Carbon, 50 (2). pp. 622-632.

Coley, HM, Safuwan, NA, Chivers, P, Papacharalbous, E, Giannopoulos, T, Butler-Manuel, S, Madhuri, K, Lovell, DP and Crook, T (2012) The cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer. Br J Cancer, 106 (3). pp. 482-489.

Coley, HM, Hatzimichael, E, Blagden, S, McNeish, I, Thompson, A, Crook, T and Syed, N (2012) Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in ovarian cancer. Oncotarget, 3 (1). pp. 78-83.

Neves, V, Gerondopoulos, A, Heister, E, Tîlmaciu, C, Flahaut, E, Soula, B, Silva, SRP, McFadden, J and Coley, HM (2012) Cellular localization, accumulation and trafficking of double-walled carbon nanotubes in human prostate cancer cells Nano Research, 5 (4). pp. 223-234.

Sanz, V, Coley, HM, Silva, SRP and McFadden, J (2012) Modeling the binding of peptides on carbon nanotubes and their use as protein and DNA carriers Journal of Nanoparticle Research, 14 (2).

Ajabnoor, GM, Crook, T and Coley, HM (2012) Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells. Cell death and Disease, 3.

Sanz, V, Coley, HM, McFadden, J, Sanz, V and Silva, SRP (2012) Protamine and chloroquine enhance gene delivery and expression mediated by RNA-wrapped single walled carbon nanotubes Journal of Nanoscience and Nanotechnology, 12 (3). pp. 1739-1747.

Sanz, V, Tilmacîu, C, Soula, B, Flahaut, E, Coley, HM, Silva, SRP and McFadden, J (2011) Chloroquine-enhanced gene delivery mediated by carbon nanotubes Carbon, 49 (15). pp. 5348-5358.

Syed, N, Coley, HM, Sehouli, J, Koensgen, D, Mustea, A, Szlosarek, P, McNeish, I, Blagden, SP, Schmid, P and Lovell, DP (2011) Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer. Cancer Res, 71 (9). pp. 3317-3327.

Sanz, V, Borowiak, E, Lukanov, P, Galibert, AM, Flahaut, E, Coley, HM, Silva, SRP and McFadden, J (2011) Optimising DNA binding to carbon nanotubes by non-covalent methods Carbon, 49 (5). pp. 1775-1781.

Sanz, V, Borowiak, E, Lukanov, P, Galibert, AM, Flahaut, E, Coley, HM, Silva, SRP and McFadden, J (2011) Optimising DNA binding to carbon nanotubes by non-covalent methods Carbon, 49 (5). pp. 1775-1781.

Neves, V, Heister, E, Costa, S, Tîlmaciu, C, Borowiak-Palen, E, Giusca, CE, Flahaut, E, Soula, B, Coley, HM, McFadden, J and Silva, SRP (2010) Uptake and release of double-walled carbon nanotubes by mammalian cells Advanced Functional Materials, 20 (19). pp. 3272-3279.

Foster, H, Coley, HM, Goumenou, A, Pados, G, Harvey, A and Karteris, E (2010) Differential Expression of mTOR Signalling Components in Drug Resistance in Ovarian Cancer ANTICANCER RESEARCH, 30 (9). pp. 3529-3534.

Mulholland, DA, Langat, MK, Crouch, NR, Coley, HM, Mutambi, EM and Nuzillard, J-M (2010) Cembranolides from the stem bark of the southern African medicinal plant, Croton gratissimus (Euphorbiaceae) PHYTOCHEMISTRY, 71 (11-12). pp. 1381-1386.

Heister, E, Lamprecht, C, Neves, V, Tilmaciu, C, Datas, L, Flahaut, E, Soula, B, Hinterdorfer, P, Coley, HM, Silva, SRP and McFadden, J (2010) Higher Dispersion Efficacy of Functionalized Carbon Nanotubes in Chemical and Biological Environments ACS NANO, 4 (5). pp. 2615-2626.

Heister, E, Lamprecht, C, Neves, V, Tilmaciu, C, Datas, L, Flahaut, E, Soula, B, Hinterdorfer, P, Coley, HM, Silva, SRP and McFadden, J (2010) Higher Dispersion Efficacy of Functionalized Carbon Nanotubes in Chemical and Biological Environments ACS NANO, 4 (5). pp. 2615-2626.

Hatzimichael, E, Dasoula, A, Shah, R, Syed, N, Papoudou-Bai, A, Coley, HM, Dranitsaris, G, Bourantas, KL, Stebbing, J and Crook, T (2010) The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia EUROPEAN JOURNAL OF HAEMATOLOGY, 84 (1). pp. 47-51.

Coley, HM (2010) Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors. Methods Mol Biol, 596. pp. 341-358.

Lamprecht, C, Liashkovich, I, Neves, V, Danzberger, J, Heister, E, Rangl, M, Coley, HM, McFadden, J, Flahaut, E, Gruber, HJ, Hinterdorfer, P, Kienberger, F and Ebner, A (2009) AFM imaging of functionalized carbon nanotubes on biological membranes NANOTECHNOLOGY, 20 (43), ARTN 43400.

Hatzimichael, E, Benetatos, L, Dasoula, A, Dranitsaris, G, Tsiara, S, Georgiou, I, Syrrou, M, Stebbing, J, Coley, HM, Crook, T and Bourantas, KL (2009) Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia LEUKEMIA RESEARCH, 33 (9). pp. 1272-1275.

Heister, E, Neves, V, Tilmaciu, C, Lipert, K, Beltran, VS, Coley, HM, Silva, SRP and McFadden, J (2009) Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy CARBON, 47 (9). pp. 2152-2160.

Heister, E, Neves, V, Tilmaciu, C, Lipert, K, Beltran, VS, Coley, HM, Silva, SRP and McFadden, J (2009) Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy CARBON, 47 (9). pp. 2152-2160.

Sooriakumaran, P, Coley, HM, Fox, SB, Macanas-Pirard, P, Lovell, DP, Henderson, A, Eden, CG, Miller, PD, Langley, SEM and Laing, RW (2009) A Randomized Controlled Trial Investigating the Effects of Celecoxib in Patients with Localized Prostate Cancer ANTICANCER RESEARCH, 29 (5). pp. 1483-1488.

Coley, HM (2009) Mechanisms and consequences of chemotherapy resistance in breast cancer EJC SUPPL, 7 (1). pp. 3-7.

Sooriakumaran, P, Macanas-Pirard, P, Bucca, G, Henderson, A, Langley, SE, Laing, RW, Smith, CP, Laing, EE and Coley, HM (2009) A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer. Cancer Genomics Proteomics, 6 (2). pp. 93-99.

Lopez, J, Percharde, M, Coley, HM, Webb, A and Crook, T (2009) The context and potential of epigenetics in oncology BRITISH JOURNAL OF CANCER, 100 (4). pp. 571-577.

Coley, HM (2008) Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer CANCER TREATMENT REVIEWS, 34 (4). pp. 378-390.

Mehar, A, Macanas-Pirard, P, Mizokami, A, Takahashi, Y, Kass, GEN and Coley, HM (2008) The effects of cyclooxygenase-2 expression in prostate cancer cells: Modulation of response to cytotoxic agents JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 324 (3). pp. 1181-1187.

Duncan, L, Shelmerdine, H, Hughes, MP, Coley, HM, Huebner, Y and Labeed, FH (2008) Dielectrophoretic analysis of changes in cytoplasmic ion levels due to ion channel blocker action reveals underlying differences between drug-sensitive and multidrug-resistant leukaemic cells PHYSICS IN MEDICINE AND BIOLOGY, 53 (2). N1-N7.

Coley, HM, Sarju, J and Wagner, G (2008) Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines JOURNAL OF MEDICINAL CHEMISTRY, 51 (1). pp. 135-141.

Fojo, T and Coley, HM (2007) The role of efflux pumps in drug-resistant metastatic breast cancer: New insights and treatment strategies CLINICAL BREAST CANCER, 7 (10). pp. 749-756.

Coley, HM, Shotton, CF, Kokkinos, MI and Thomas, H (2007) The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines GYNECOLOGIC ONCOLOGY, 105 (2). pp. 462-469.

Coley, HM, Labeed, FH, Thomas, H and Hughes, MP (2007) Biophysical characterization of MDR breast cancer cell lines reveals the cytoplasm is critical in determining drug sensitivity BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1770 (4). pp. 601-608.

Sooriakumaran, P, Langley, SEM, Laing, RW and Coley, HM (2007) COX-2 inhibition: A possible role in the management of prostate cancer? JOURNAL OF CHEMOTHERAPY, 19 (1). pp. 21-32.

Lewis, LJ, Mistry, P, Charlton, PA, Thomas, H and Coley, HM (2007) Mode of action of the novel phenazine anticancer agents XR11576 and XR5944 ANTI-CANCER DRUGS, 18 (2). pp. 139-148.

Coley, HM, Shotton, CF and Thomas, H (2007) Selicielib (CYC202; r-roscovitine) in combination with cytotoxic agents in human uterine sarcoma cell lines ANTICANCER RESEARCH, 27 (1A). pp. 273-278.

Duncan, L, Shelmerdine, H, Coley, HM and Labeed, FH (2006) Assessment of the dielectric properties of drug sensitive and resistant leukaemic cells before and after ion channel blockers using dielectroplioresis 2006 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2006 Technical Proceedings, 2. pp. 45-48.

Coley, HM, Shotton, CF, Ajose-Adeogun, A, Modjtahedi, H and Thomas, H (2006) Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents BIOCHEMICAL PHARMACOLOGY, 72 (8). pp. 941-948.

Labeed, FH, Coley, HM and Hughes, MP (2006) Differences in the biophysical properties of membrane and cytoplasm of apoptotic cells revealed using dielectrophoresis BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1760 (6). pp. 922-929.

Chin, S, Hughes, MP, Coley, HM and Labeed, FH (2006) Rapid assessment of early biophysical changes in K562 cells during apoptosis determined using dielectrophoresis INTERNATIONAL JOURNAL OF NANOMEDICINE, 1 (3). pp. 333-337.

Labeed, FH, Coley, HM, Thomas, H and Hughes, MP (2003) Assessment of multidrug resistance reversal using dielectrophoresis and flow cytometry BIOPHYSICAL JOURNAL, 85 (3). pp. 2028-2034.

Lewandowicz, GM, Britt, P, Elgie, AW, Williamson, CJ, Coley, HM, Hall, AG and Sargent, JM (2002) Cellular glutathione content, in vitro chemoresponse, and the effect of BSO modulation in samples derived from patients with advanced ovarian cancer GYNECOLOGIC ONCOLOGY, 85 (2). pp. 298-304.

Coley, HM, Sargent, JM, Williamson, CJ, Titley, J, Scheper, RJ, Gregson, SE, Elgie, AW, Lewandowicz, GM and Taylor, CG (2002) Assessment of the classical MDR phenotype in epithelial ovarian carcinoma using primary cultures: A feasibility study ANTICANCER RESEARCH, 22 (1A). pp. 69-74.

Lewis, JS, Dearling, JLJ, Sosabowski, JK, Zweit, J, Carnochan, P, Kelland, LR, Coley, HM and Blower, PJ (2000) Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 27 (6). pp. 638-646.

Coley, HM, Verrill, MW, Gregson, SE, Odell, DE, Fisher, C and Judson, IR (2000) Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma EUROPEAN JOURNAL OF CANCER, 36 (7). pp. 881-888.

Coley, HM, Sargent, JM, Titley, J and Taylor, CG (1999) Lack of prognostic significance of ploidy and S-phase measurements in advanced ovarian cancer ANTICANCER RESEARCH, 19 (3A). pp. 2111-2116.

Sargent, JM, Coley, HM, Williamson, C and Taylor, C (1998) Evidence of ABC transporters in fresh tumor cells from patients with ovarian cancer INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 36 (2). pp. 64-66.

Coley, HM (1997) N-(hydroxymethyl) melamines GENERAL PHARMACOLOGY, 28 (2). pp. 177-182.

Coley, HM, Lewandowicz, G, Sargent, JM and Verrill, MW (1997) Chemosensitivity testing of fresh and continuous tumor cell cultures using lactate dehydrogenase ANTICANCER RESEARCH, 17 (1A). pp. 231-236.

Coley, HM, Jarman, M, Brooks, N, Kubota, T, Goddard, PM, Jones, M, Lee, N, Owens, MD, Halbert, GW and Judson, IR (1996) Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol INTERNATIONAL JOURNAL OF CANCER, 68 (3). pp. 356-363.

Yamada, Y, Kubota, T, Hoshiya, Y, Asanuma, F, Koh, JI, Kitajima, M, Coley, HM and Judson, IR (1996) Antitumor effect of trimelamol against human breast carcinoma xenografts in nude mice ONCOLOGY REPORTS, 3 (4). pp. 613-617.

Coley, HM, Jarman, M, Jones, M, Sargent, JM, Kubota, T, Lee, NCJ, Goddard, PM, Elgie, AW, Williamson, C, Taylor, CG and Judson, IR (1996) The activity of N-(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenografts ANTICANCER RESEARCH, 16 (4A). pp. 1851-1855.

Conference or Workshop Item

Montaser, R, Coley, HM, Crook, TM and Ajabnoor, GA (2012) Molecular Mechanisms and Cell Death Pathways in Targeted Therapy-Resistant Breast Cancer In: 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2012-11-06 - 2012-11-09, European Org Res & Treatment Canc (EORTC), Dublin, IRELAND.

Jeynes, JCG, Bailey, MJ, Coley, H, Kirkby, KJ and Jeynes, C (2010) Microbeam PIXE analysis of platinum resistant and sensitive ovarian cancer cells

Sooriakumaran, P, Laing, R, Macanas-Pirard, P, Coley, H, Fox, S, Bucca, G, Lovell, D, Henderson, A, Smith, C, Eden, C, Miller, P and Langley, S (2007) A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with cT1-2 prostate cancer In: 102nd Annual Meeting of the American-Urological-Association, 2007-05-19 - 2007-05-24, Anaheim, CA.

Sooriakumaran, P, Langley, SEM, Laing, RW, Coley, HM, Fox, SB and Eden, C (2007) A blinded, randomised controlled trial of neo-adjuvant Celecoxib in patients with localised prostate cancer In: 60th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, 2007-02-18 - 2007-02-22, Adelaide, AUSTRALIA.

Sooriakumaran, P, Macanas-Pirard, P, Fox, S, Coley, H, Bucca, G, Lovell, D, Henderson, A, Smith, C, Langley, S and Laing, R (2006) A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with early prostate cancer. In: 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, 2006-06-02 - 2006-06-06, Atlanta, GA.

Labeed, FH, Chin, S, Broche, LM, Coley, HM, Thomas, H and Hughes, M (2005) Rapid assessment of biophysical changes in K562 cells during apoptosis, determined using dielectrophoresis In: 49th Annual Meeting of the Biopysical-Society, 2005-02-12 - 2005-02-16, Long Beach, CA.

Labeed, FH, Hughes, MP, Charlton, P and Coley, HM (2002) Assessment of modulator action on drug-resistant and sensitive cancer cells using dielectrophoretic methods

This list was generated on Wed Nov 22 20:39:00 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800